Galectin-9 - ligand axis: an emerging therapeutic target for multiple myeloma.
Saved in:
| Title: | Galectin-9 - ligand axis: an emerging therapeutic target for multiple myeloma. |
|---|---|
| Authors: | Shil RK; Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States., Mohammed NBB; The Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, NY, United States.; Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt., Dimitroff CJ; Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Sep 25; Vol. 15, pp. 1469794. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1469794 |
